Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 5, 2012, Pages 575-583

  Hayashi, Makoto ^a   Takayanagi, Noboru ^a   Kanauchi, Tetsu ^a   Miyahara, Yousuke ^a   Yanagisawa, Tsutomu ^a   Sugita, Yutaka ^a  

^a Saitama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

Bronchiectasis; Lung infection; Mycobacterium avium intracellulare complex; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; BRONCHIECTASIS; COMORBIDITY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALBUMINEMIA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HIV SERONEGATIVITY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; LUNG DISEASES; MALE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84857875795     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201107-1203OC     Document Type: Article

References (44)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee. American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416. (Pubitemid 46271561)
2. Andréjak C, Thomsen VØ, Johansen LS, Riis A, Thomas LB, Duhaut P, Sørensen HT, Lescure F, Thomsen RW. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010;181:514-521.
3. Field SK, Cowie L. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006;129:1653-1672. (Pubitemid 43894999)
4. Prevots DR, Shaw PA, Strickland D, Jackson LA, Reabel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-976.
5. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-982.
6. Kennedy TP, Weber DJ. Nontuberculous mycobacteria. An underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med 1994;149:1654-1658. (Pubitemid 24175990)
7. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-348. (Pubitemid 43289853)
8. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007;62:661-666. (Pubitemid 47235003)
9. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124-e129.
10. O'Brien RJ, Geiter LJ, Snider DE Jr, . The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-1014. (Pubitemid 18021482)
11. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992;101:1605-1609.
12. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321: 863-868. (Pubitemid 19238618)
13. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566-581. (Pubitemid 39093445)
14. Hunter AM, Campbell IA, Jenkins PA, Smith AP. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax 1981;36:326-329. (Pubitemid 11105823)
15. Davidson PT, Khanijo V, Goble M, Moulding TS. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis 1981;3:1052-1059.
16. Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1986;134:438-441.
17. Etzkorn ET, Aldarond S, McAllister CK, Matthews J, Ognibene J. Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis 1986;134:442-445. (Pubitemid 16014400)
18. Horsburgh CR Jr, Mason UG III, Heifets LB, Southwick K, Labrecque J, Iseman MD. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis 1987;135:418-421.
19. Dutt AK, Stead WW. Long-term results of medical treatment in Mycobacterium intracellulare infection. Am J Med 1979;67:449-453. (Pubitemid 10237029)
20. Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;174:928-934. (Pubitemid 44564794)
21. Lam PK, Griffith DE, Aksamit RA, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173:1283-1289. (Pubitemid 43848401)
22. Tanaka E, Kimoto T, Tsuyugushi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866-872. (Pubitemid 29442022)
23. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonaryMycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med 1996;153:1766-1772. (Pubitemid 26187897)
24. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994;149:1335-1341. (Pubitemid 24147078)
25. Dautzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 1995;107:1035-1040.
26. Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. Chest 2003;124:1482-1486. (Pubitemid 37290061)
27. Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A. Therapeutic effect of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease. Chest 2009;136:1569-1575.
28. Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000;30:288-292. (Pubitemid 30131535)
29. Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, et al. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 1999;29:125-133. (Pubitemid 29336814)
30. Kobashi Y, Matsushima T. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern Med 2003;42:670-675. (Pubitemid 37021197)
31. Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56:167-172.
32. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung disease and assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63:627-634. (Pubitemid 351969257)
33. Andréjak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, Schmit JL, Jounieaux V. Xenopi Group. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009;64:291-296.
34. Hayashi M, Takayanagi N, Ishiguro T, Yoneda K, Aoki N, Miyahara Y, Aoki H, Tokunaga D, Kurashima K, Yanagisawa T, et al. Clinical course and long-term prognosis of MAC-LD [abstract]. Nihon Kokyuki Gakkai Zasshi 2010;48:S211.
35. Okumura M, Iwai K, Ogata H, Yoshihama T, Yoshimori K, Mizutani S, Sugita H, Azuma A, Kudoh S. Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2006;44:3-12.
36. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulareavium in Texas. Chest 1979;75:120-125. (Pubitemid 9128101)
37. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008;133:243-251.
38. Aksamit TR. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 2002;23:643-653.
39. Kikuchi T, Watanabe A, Gomi K, Sakakibara T, Nishimori K, Daito H, Fujimura S, Tazawa R, Inoue A, Ebina M, et al. Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection. Thorax 2009;64:901-907.
40. Maekura R, Okuda Y, Hirotani A, Kitada S, Hiraga T, Yoshimura K, Yano I, Kobayashi K, Ito M. Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients. J Clin Microbiol 2005;43:3150-3158. (Pubitemid 40981316)
41. Wallace RJ Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. Polyclonal Mycobacterium avium complex infection in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998;158:1235-1244. (Pubitemid 28489028)
42. Andréjak C, Lescure FX, Douadi Y, Laurans G, Smail A, Duhaut P, Jounieaux V, Schmit JL. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients. J Infect 2007;55:34-40. (Pubitemid 46888075)
43. The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow up of patients receiving standardised treatment. Int J Tuberc Lung Dis 2002;6:628-634.
44. Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-2046. (Pubitemid 27256136)